- What other names is Banaba known by?
- What is Banaba?
- How does Banaba work?
- Are there safety concerns?
- Are there any interactions with medications?
- Dosing considerations for Banaba.
Banaba Extract, Banabalean, Corosolic acid, Crape Myrtle, Crepe Myrtle, Extrait de Banaba, Lagerstroemia flos-reginae, Lagerstroemia speciosa, Munchausia speciosa, Myrte de Crêpe, Pride-of-India, Pyinma, Queen's Crape Myrtle.
Banaba is a species of crepe myrtle tree that is native to the Philippines and Southeast Asia. People use the leaves to make medicine.
Insufficient Evidence to Rate Effectiveness for...
- Diabetes. Some early research suggests that taking a particular banaba extract (Glucosol) for 2 weeks lowers blood sugar by 10% in people with type 2 diabetes. However, other early research suggests that taking a single dose of corosolic acid, a chemical in banaba, before eating does not improve post-meal sugar tolerance.
- Weight loss.
- Other conditions.
Banaba is POSSIBLY SAFE for most people when taken by mouth on a short-term basis. The long-term safety is unknown.
Special Precautions & Warnings:Pregnancy and breast-feeding: Not enough is known about the use of banaba during pregnancy and breast-feeding. Stay on the safe side and avoid use.
Diabetes: Banaba can affect blood sugar control, so people with diabetes should monitor their blood glucose levels closely. If you have diabetes, it's best to check with your healthcare provider before starting banaba.
Surgery: Banaba might affect blood sugar levels and could make blood sugar control more difficult during and after surgery. Stop using banaba at least 2 weeks before a scheduled surgery.
Medications for diabetes (Antidiabetes drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Banaba might decrease blood sugar. Diabetes medications are also used to lower blood sugar. Taking banaba along with diabetes medications might cause your blood sugar to go too low. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.
Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.
Medications for high blood pressure (Antihypertensive drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Banaba might decrease blood pressure. Taking banaba along with medications used for lowering high blood pressure might cause your blood pressure to go too low. Do not take too much banaba if you are taking medications for high blood pressure. Some medications for high blood pressure include nifedipine (Adalat, Procardia), verapamil (Calan, Isoptin, Verelan), diltiazem (Cardizem), isradipine (DynaCirc), felodipine (Plendil), amlodipine (Norvasc), and others.
Medications moved by pumps in cells (Organic Anion-Transporting Polypeptide Substrates)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.
Some medications are moved by pumps in cells. Banaba might change how these pumps work and decrease how much of some medications get absorbed by the body. This could make these medications less effective. Some of these medications that are moved by pumps in cells include bosentan (Tracleer), celiprolol (Celicard, others), etoposide (VePesid), fexofenadine (Allegra), fluoroquinolone antibiotics, glyburide (Micronase, Diabeta), irinotecan (Camptosar), methotrexate, nadolol (Corgard), paclitaxel (Taxol), saquinavir (Fortovase, Invirase), rifampin, statins, talinolol, torsemide (Demadex), troglitazone, and valsartan (Diovan).
The appropriate dose of banaba depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for banaba. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Health Solutions From Our Sponsors
Ali, H., Houghton, P. J., and Soumyanath, A. alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol. 10-11-2006;107(3):449-455. View abstract.
Bai, N., He, K., Roller, M., Zheng, B., Chen, X., Shao, Z., Peng, T., and Zheng, Q. Active compounds from Lagerstroemia speciosa, insulin-like glucose uptake-stimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Agric.Food Chem 12-24-2008;56(24):11668-11674. View abstract.
Choi, H. J., Bae, E. Y., Song, J. H., Baek, S. H., and Kwon, D. H. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication. Lett.Appl.Microbiol. 2010;51(1):1-5. View abstract.
Fukushima, M., Matsuyama, F., Ueda, N., Egawa, K., Takemoto, J., Kajimoto, Y., Yonaha, N., Miura, T., Kaneko, T., Nishi, Y., Mitsui, R., Fujita, Y., Yamada, Y., and Seino, Y. Effect of corosolic acid on postchallenge plasma glucose levels. Diabetes Res Clin Pract 2006;73(2):174-177. View abstract.
Gao, S., Zhan, Q., Li, J., Yang, Q., Li, X., Chen, W., and Sun, L. LC-MS/MS method for the simultaneous determination of ethyl gallate and its major metabolite in rat plasma. Biomed.Chromatogr. 2010;24(5):472-478. View abstract.
Garcia, L. L et al. Pharmaceutico-chemical and pharmacological studies on a crude drug from Lagerstroemia speciosa (L.) Pers. Philippine J Sci 1987;116:361-375.
Hou, W., Li, Y., Zhang, Q., Wei, X., Peng, A., Chen, L., and Wei, Y. Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors. Phytother.Res 2009;23(5):614-618. View abstract.
Ichikawa, H., Yagi, H., Tanaka, T., Cyong, J. C., and Masaki, T. Lagerstroemia speciosa extract inhibit TNF-induced activation of nuclear factor-kappaB in rat cardiomyocyte H9c2 cells. J Ethnopharmacol. 3-2-2010;128(1):254-256. View abstract.
Khan, M. T., Lampronti, I., Martello, D., Bianchi, N., Jabbar, S., Choudhuri, M. S., Datta, B. K., and Gambari, R. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int.J.Oncol. 2002;21(1):187-192. View abstract.
Klein, G., Kim, J., Himmeldirk, K., Cao, Y., and Chen, X. Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa. Evid.Based Complement Alternat.Med 2007;4(4):401-407. View abstract.
Lampronti, I., Khan, M. T., Bianchi, N., Ather, A., Borgatti, M., Vizziello, L., Fabbri, E., and Gambari, R. Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites. Med Chem 2005;1(4):327-333. View abstract.
Liu, F., Kim, J., Li, Y., Liu, X., Li, J., and Chen, X. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr 2001;131(9):2242-2247. View abstract.
Liu, X., Kim, J. K., Li, Y., Li, J., Liu, F., and Chen, X. Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J Nutr 2005;135(2):165-171. View abstract.
Murakami, C., Myoga, K., Kasai, R., Ohtani, K., Kurokawa, T., Ishibashi, S., Dayrit, F., Padolina, W. G., and Yamasaki, K. Screening of plant constituents for effect on glucose transport activity in Ehrlich ascites tumour cells. Chem Pharm Bull (Tokyo) 1993;41(12):2129-2131. View abstract.
Nahar, LI, Ripa, FA, and Al-Bari, MA. Investigation on Antioxidant Activities of Six Indigenous Plants of Bangladesh. Journal of Applied Sciences Research 2009;5(12):2285-2288.
Nicolis, E., Lampronti, I., Dechecchi, M. C., Borgatti, M., Tamanini, A., Bezzerri, V., Bianchi, N., Mazzon, M., Mancini, I., Giri, M. G., Rizzotti, P., Gambari, R., and Cabrini, G. Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen. Int Immunopharmacol. 2009;9(12):1411-1422. View abstract.
Okada, Y., Omae, A., and Okuyama, T. A new triterpenoid isolated from Lagerstronemia speciosa (L.) Pers. Chem Pharm Bull (Tokyo) 2003;51(4):452-454. View abstract.
Osawa, K., Ueda, J., and Takahashi, M. [The components of the plants of Lagerstroemia genus. II. Studies on the components of the leaves of Lagerstroemia speciosa (L.) Pers., L. subcostata Koehne., L. indica Linn., and L. fauriei Koehne (author's transl)]. Yakugaku Zasshi 1974;94(2):271-273. View abstract.
Priya, T. T., Sabu, M. C., and Jolly, C. I. Amelioration of cisplatin induced nephrotoxicity in mice by an ethyl acetate extract of Lagerstroemia speciosa (L). J Basic Clin Physiol Pharmacol 2007;18(4):289-298. View abstract.
Priya, T. T., Sabu, M. C., and Jolly, C. I. Free radical scavenging and anti-inflammatory properties of Lagerstroemia speciosa (L). Inflammopharmacology. 2008;16(4):182-187. View abstract.
Ragasa, C. Y., Ngo, H. T., and Rideout, J. A. Terpenoids and sterols from Lagerstroemia speciosa. J Asian Nat Prod Res 2005;7(1):7-12. View abstract.
Sato, J., Goto, K., Nanjo, F., Kawai, S., and Murata, K. Antifungal activity of plant extracts against Arthrinium sacchari and Chaetomium funicola. J Biosci.Bioeng. 2000;90(4):442-446. View abstract.
Shim, K. S., Lee, S. U., Ryu, S. Y., Min, Y. K., and Kim, S. H. Corosolic acid stimulates osteoblast differentiation by activating transcription factors and MAP kinases. Phytother.Res 2009;23(12):1754-1758. View abstract.
Sinhababu, A., Basak, B., Laskar, S., Chakrabarty, D., and Sen, S. K. Effect of different fractions of petroleum ether (60-80 degrees) extract of the seeds of Lagerstroemia speciosa (Linn. ex Murray) Pers. on some microorganisms. Hindustan Antibiot.Bull 1994;36(1-2):39-45. View abstract.
Sivakumar, G., Vail, D. R., Nair, V., Medina-Bolivar, F., and Lay, J. O., Jr. Plant-based corosolic acid: future anti-diabetic drug? Biotechnol.J 2009;4(12):1704-1711. View abstract.
Takagi, S., Miura, T., Ishibashi, C., Kawata, T., Ishihara, E., Gu, Y., and Ishida, T. Effect of corosolic acid on the hydrolysis of disaccharides. J Nutr Sci Vitaminol.(Tokyo) 2008;54(3):266-268. View abstract.
Takagi, S., Miura, T., Ishihara, E., Ishida, T., and Chinzei, Y. Effect of corosolic acid on dietary hypercholesterolemia and hepatic steatosis in KK-Ay diabetic mice. Biomed.Res 2010;31(4):213-218. View abstract.
Takahashi, M., Osawa, K., Ueda, J., Yamamoto, F., and Tsai, C. T. [The components of the plants of Lagerstroemia genus. III. On the structure of the new tannin "lagertannin" from the leaves of Lagerstroemia speciosa (L.) Pers. (author's transl)]. Yakugaku Zasshi 1976;96(8):984-987. View abstract.
Takahashi, M., Ueda, J., and Sasaki, J. I. [The components of the plants of Lagerstroemia genus. IV. On the presence of the ellagic acid derivatives from the leaves of Lagerstroemia subcostata Koehne. and L. speciosa (L.) Pers. and the synthesis of 3,4-di-o-methylellagic acid (author's transl)]. Yakugaku Zasshi 1977;97(8):880-882. View abstract.
Takahashi, M., Ueda, J., and Sasaki, J. I. [The components of the plants of Lagerstroemia genus. V. Synthesis of the aglycon of lagertannin 3,4-di-O-methylellagic acid from gallic acid (author's transl)]. Yakugaku Zasshi 1977;97(11):1236-1239. View abstract.
Yamada, K., Hosokawa, M., Fujimoto, S., Fujiwara, H., Fujita, Y., Harada, N., Yamada, C., Fukushima, M., Ueda, N., Kaneko, T., Matsuyama, F., Yamada, Y., Seino, Y., and Inagaki, N. Effect of corosolic acid on gluconeogenesis in rat liver. Diabetes Res Clin Pract 2008;80(1):48-55. View abstract.
Yamada, K., Hosokawa, M., Yamada, C., Watanabe, R., Fujimoto, S., Fujiwara, H., Kunitomo, M., Miura, T., Kaneko, T., Tsuda, K., Seino, Y., and Inagaki, N. Dietary corosolic acid ameliorates obesity and hepatic steatosis in KK-Ay mice. Biol Pharm Bull 2008;31(4):651-655. View abstract.
Yamaguchi, Y., Yamada, K., Yoshikawa, N., Nakamura, K., Haginaka, J., and Kunitomo, M. Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 11-25-2006;79(26):2474-2479. View abstract.
Fuchikami H, Satoh H, Tsujimoto M, Ohdo S, Ohtani H, Sawada Y. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 2006;34:577-82. View abstract.
Hattori K, Sukenobu N, Sasaki T, et al. Activation of insulin receptors by lagerstroemin. J Pharmacol Sci 2003;93:69-73. View abstract.
Hayashi T, Maruyama H, Kasai R, et al. Ellagitannins from Lagerstroemia speciosa as activators of glucose transport in fat cells. Planta Med 2002;68:173-5. View abstract.
Judy WV, Hari SP, Stogsdill WW, et al. Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics. A dose-dependence study. J Ethnopharmacol 2003;87:115-7. View abstract.
Kakuda T, Sakane I, Takihara T, et al. Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically diabetic KK-AY mice. Biosci Biotechnol Biochem 1996;60:204-8. View abstract.
Suzuki Y, Unno T, Ushitani M, et al. Antiobesity activity of extracts from Lagerstroemia speciosa L. leaves on female KK-Ay mice. J Nutr Sci Vitaminol (Tokyo) 1999;45:791-5. View abstract.
Unno T, Sugimoto A, Kakuda T. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers. J Ethnopharmacol 2004;93:391-5. View abstract.